title: N2- and C8-substituted oligodeoxynucleotides with enhanced thrombin inhibitory activity in vitro and in vivo.
abstract: 2'-Deoxyguanosine (G) analogues carrying various hydrophobic substituents in the N2 and C8 positions were synthesized and introduced through solid-phase synthesis into 15-mer oligodeoxynucleotide, GGTTGGTGTGGTTGG, which forms a chairlike structure consisting of two G-tetrads and is a potent thrombin inhibitor. The effects of the substitutions at N2 and C8 of the G-tetrad-forming G residues on the thrombin inhibitory activity are relatively small, suggesting that these substitutions cause relatively small perturbations on the chairlike structure formed by the oligodeoxynucleotide. Introduction of a benzyl group into N2 of G6 and G11 and naphthylmethyl groups into N2 of G6 increased the thrombin inhibitory activity, whereas other substituents in these positions had almost no effect or decreased the activity. Particularly, the oligodeoxynucleotide carrying a 1-naphthylmethyl group in the N2 position of G6 showed an increase in activity by about 60% both in vitro and in vivo. Substitutions on the N2 position of other G residues had little effect or decreased the activity. Introduction of a relatively small group, such as methyl and propynyl, into the C8 positions of G1, G5, G10, and G14 increased the activity, presumably due to the stabilization of a chairlike structure, whereas introduction of a large substituent group, phenylethynyl, decreased the activity, probably due to the steric hindrance.
authors.affiliation: Gilead Sciences, 353 Lakeside Drive, Foster City, California 94404, USA.
authors.forename: G X
authors.initials: GX
authors.lastname: He
authors.forename: S H
authors.initials: SH
authors.lastname: Krawczyk
authors.forename: S
authors.initials: S
authors.lastname: Swaminathan
authors.forename: R G
authors.initials: RG
authors.lastname: Shea
authors.forename: J P
authors.initials: JP
authors.lastname: Dougherty
authors.forename: T
authors.initials: T
authors.lastname: Terhorst
authors.forename: V S
authors.initials: VS
authors.lastname: Law
authors.forename: L C
authors.initials: LC
authors.lastname: Griffin
authors.forename: S
authors.initials: S
authors.lastname: Coutré
authors.forename: N
authors.initials: N
authors.lastname: Bischofberger
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D003849:Deoxyguanosine / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D008252:Macaca fascicularis; D009690:Nucleic Acid Conformation; D009838:Oligodeoxyribonucleotides / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D011517:Prothrombin Time; D013329:Structure-Activity Relationship; D013917:Thrombin / Q000037:antagonists & inhibitors*
chemical_list: D000925:Anticoagulants; D004791:Enzyme Inhibitors; D009838:Oligodeoxyribonucleotides; D013917:Thrombin; D003849:Deoxyguanosine